Table 1 Characteristics of participants
Characteristics | ATB (n = 30) | LTBI (n = 35) | HC (n = 36) | Total (n = 101) |
|---|---|---|---|---|
Sex (M / F) | 13/17 | 4/31 | 8/28 | 25/76 |
Age (mean ± SD) | 48 ± 18 | 40 ± 9 | 36 ± 10 | 41 ± 13 |
Complications (n, %) | ||||
 Malignancy | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
 Renal failure | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
 Diabetes mellitus | 1(3.3%) | 0(0.0%) | 0(0.0%) | 1(1.0%) |
 TB history | 2(6.7%) | 0(0.0%) | 0(0.0%) | 2(2.0%) |
 Autoimmune diseases | 1(3.3%) | 0(0.0%) | 0(0.0%) | 1(1.0%) |
Corticosteroid therapy | 1(3.3%) | 0(0.0%) | 0(0.0%) | 1(1.0%) |
Immunosuppressants | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) |
Blood tests | ||||
 WBC(*109/L) | 6.96 ± 2.50 | 6.31 ± 1.63 | 6.51 ± 1.83 | 6.59 ± 2.01 |
 Lymphocyte(*109/L) | 1.49 ± 0.58 | 2.01 ± 0.45 | 2.23 ± 0.63 | 1.91 ± 0.63 |